Issue 6, 2012

Homologous piperazine-alcanols: chiral pool synthesis and pharmacological evaluation

Abstract

Starting with the proteinogenic amino acids (S)-aspartate and (S)-glutamate the homologous piperazine-alcanols 3 and 4 were prepared in a five step synthesis. The diversity was introduced by N-1 alkylation of the piperazinediones 5 and 6 with various alkyl halides. Subsequent LiAlH4 reduction of the dioxopiperazine-esters 7 and 8 provided the alcohols 3 and 4. The ethanol derivatives 3 show similar σ1 affinity as the methanol derivatives 2, but increased selectivity over the σ2 subtype. The corresponding propanol derivatives 4 are considerably less potent. A benzyl or dimethylallyl residue at N-1 appears to be optimal for high σ1 affinity.

Graphical abstract: Homologous piperazine-alcanols: chiral pool synthesis and pharmacological evaluation

Article information

Article type
Concise Article
Submitted
09 Mar 2012
Accepted
06 May 2012
First published
08 May 2012

Med. Chem. Commun., 2012,3, 673-679

Homologous piperazine-alcanols: chiral pool synthesis and pharmacological evaluation

R. Holl, D. Schepmann and B. Wünsch, Med. Chem. Commun., 2012, 3, 673 DOI: 10.1039/C2MD20070H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements